Paper Details

Paper Title

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.

Paper Journal Title

Leukemia and Lymphoma

Paper Citation Count

Paper Publication Year

2006

Bio Mention

B-, CD34, CD34+, CD34+ cell, CD34+ cells, Rituximab, anti-CD20 human-mouse chimeric monoclonal antibody, etoposide, filgrastim, human, ifosfamide, intermediate-grade B-cell non-Hodgkin's lymphoma, intermediate-grade non-Hodgkin's lymphoma, mouse, non-Hodgkin's lymphoma, patients, peripheral blood stem cell, rituximab, stem cell

Mesh Descriptor

Paper Details

Column Actions

Datasets